🚚 FREE U.S. Shipping on Orders Over $500
SKU: FOXO4-DRI-10mg

FOXO4-DRI (10mg)

FOXO4-DRI is a synthetic retro-inverso peptide, meaning it is assembled from D-amino acids in reversed sequence order relative to the native segment it is based on. The D-configuration confers resistance to proteolytic degradation. The molecule combines a sequence derived from the FOXO4 forkhead domain with a polycationic cell-penetrating carrier sequence.

In published in vitro literature, FOXO4-DRI has been characterized as an interfering peptide that competes with the FOXO4 protein for binding to p53. This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development for D-peptides, protein-protein interaction and competitive binding assays, cell-penetrating peptide uptake studies, and comparative proteolytic stability studies.

Peptide Information

  • Peptide Sequence: LTLRKEPASEIAQSILEAYSQNGWANRRSGGKRPPPRRRQRRKKRG (all D-amino acids, retro-inverso)
  • Molecular Formula: C₂₂₈H₃₈₈N₈₆O₆₄
  • Molecular Weight: ~5358 g/mol
  • CAS Number: 2460055-10-9

 

Storage & Handling
Store the lyophilized powder in a sealed container at −20 °C, protected from light and moisture. After reconstitution, store the solution at 2–8 °C and use it promptly. Avoid repeated freeze–thaw cycles. Use aseptic technique to preserve compound integrity and follow standard laboratory safety practices.

Research-Use Notice

For non-clinical in vitro laboratory research and analytical use only. Not intended for human or veterinary use, ingestion, injection, administration, compounding, clinical use, or diagnostic procedures. No representation is made regarding suitability for any clinical or therapeutic application.

$199.99

Choose Quantity

Description

FOXO4-DRI is a synthetic retro-inverso peptide, meaning it is assembled from D-amino acids in reversed sequence order relative to the native segment it is based on. The D-configuration confers resistance to proteolytic degradation. The molecule combines a sequence derived from the FOXO4 forkhead domain with a polycationic cell-penetrating carrier sequence.

In published in vitro literature, FOXO4-DRI has been characterized as an interfering peptide that competes with the FOXO4 protein for binding to p53. This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development for D-peptides, protein-protein interaction and competitive binding assays, cell-penetrating peptide uptake studies, and comparative proteolytic stability studies.

Peptide Information

  • Peptide Sequence: LTLRKEPASEIAQSILEAYSQNGWANRRSGGKRPPPRRRQRRKKRG (all D-amino acids, retro-inverso)
  • Molecular Formula: C₂₂₈H₃₈₈N₈₆O₆₄
  • Molecular Weight: ~5358 g/mol
  • CAS Number: 2460055-10-9

 

Storage & Handling
Store the lyophilized powder in a sealed container at −20 °C, protected from light and moisture. After reconstitution, store the solution at 2–8 °C and use it promptly. Avoid repeated freeze–thaw cycles. Use aseptic technique to preserve compound integrity and follow standard laboratory safety practices.

Research-Use Notice

For non-clinical in vitro laboratory research and analytical use only. Not intended for human or veterinary use, ingestion, injection, administration, compounding, clinical use, or diagnostic procedures. No representation is made regarding suitability for any clinical or therapeutic application.

Additional information

Weight 0.1 lbs
Dimensions 1 × 1 × 2 in

Disclaimer: For Research Purposes Only

This content is supplied exclusively for research and educational purposes. Nothing presented here should be interpreted as approval, promotion, or encouragement of any non-laboratory use, improper handling, or non-research application of peptides intended for scientific investigation. Any references to specific peptides, their properties, or findings associated with them are provided solely as informational research content. This information does not constitute legal advice, clinical guidance, or a recommendation for personal, therapeutic, or non-research use. These compounds are intended only for controlled scientific work conducted by qualified and authorized individuals. Before making any decision regarding the purchase, possession, handling, or use of research peptides, consultation with qualified research professionals or legal counsel is strongly advised. All information should be used responsibly, ethically, and only in connection with legitimate academic, scientific, or investigative purposes. This notice applies broadly to all peptide-related content provided here and may be updated as needed.

0